CBAS team
Some of the team at Cambridge Bio-Augmentation Systems.
Rebecca Wayman

AI-powered patient monitoring system awarded £865k Innovate UK grant

Innovate UK has awarded a £865k Digital Health Technology Catalyst grant to various partners to develop an artificial intelligence platform that analyses physical movements of patients on a daily basis.

The solution will apply to a wide range of conditions and help clinicians make data-informed decisions about patient progress and wellbeing.

Led by Cambridge Bio-Augmentation Systems (CBAS), partners in the consortium include Andiamo, which makes user-centred children’s orthotics, CUSH Health, which makes smart devices for elderly patients, and the Human Performance Lab at Queen Mary University of London.

CBAS has developed the AI platform and will be trialling it with Andiamo’s 3D printed orthoses and CUSH Health’s smart device for elderly patients at risk of falls.

Oliver Armitage, co-founder and CSO of CBAS, said: “We are so pleased to be taking our AI platform to the next stage and trying it with real patients in the field.

“Having the support and validation of Innovate UK shows the appetite for AI solutions in healthcare, and the enthusiasm of our partners shows the willingness of the industry to begin incorporating these types of solutions into their products.”

The project begins in October 2018 and will continue for 15 months. Groups of patients will be selected to trial wearable devices on their orthoses and devices in their daily lives over a few months and the readings analysed by the AI platform will then be validated by Queen Mary’s Human Performance.

The Human Performance Lab in addition to validating test results from the AI analysis - which so far has been shown to be 96 per cent accurate - will explore how to apply the novel technology to movement measurements.

The ultimate aim for a finished product is to help clinicians deliver better care as well as add greater insight and support for their patients and their families.

Naveed R. Parvez, co-founder and CEO at Andiamo, added: “We’re very excited to be collaborating with CBAS on this project. It is clear to us that the future of healthcare will and must be driven by outcomes and evidence.

“Orthotic users want to better understand their condition and their journey to an outcome, clinicians want to deliver evidence-based practice, and providers want to understand what is ‘good’.

“The support from Innovate UK will drive this critical change faster, and allow us to understand how healthcare will adopt a move to a much greater transparency in orthotic treatments.”

Explore these topics

Join the discussion as a guest or using , or Google

Top Ten Most Read